KR830010121A - 세팔로스포린 유도체의 제조방법 - Google Patents

세팔로스포린 유도체의 제조방법 Download PDF

Info

Publication number
KR830010121A
KR830010121A KR1019820002031A KR820002031A KR830010121A KR 830010121 A KR830010121 A KR 830010121A KR 1019820002031 A KR1019820002031 A KR 1019820002031A KR 820002031 A KR820002031 A KR 820002031A KR 830010121 A KR830010121 A KR 830010121A
Authority
KR
South Korea
Prior art keywords
substituted
alkyl
optionally substituted
formula
pyridine
Prior art date
Application number
KR1019820002031A
Other languages
English (en)
Other versions
KR880001541B1 (ko
Inventor
라트렐 루돌프
비이두 빌트 만프레드
뒤르크 하이머 발터
블룸바하 위르겐
Original Assignee
하인리히 베커 베른하르트 베크
훽스트 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인리히 베커 베른하르트 베크, 훽스트 아크티엔 게젤샤프트 filed Critical 하인리히 베커 베른하르트 베크
Publication of KR830010121A publication Critical patent/KR830010121A/ko
Application granted granted Critical
Publication of KR880001541B1 publication Critical patent/KR880001541B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

세팔로스포린 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 일반식(Ⅱ)의 화합물 또는 그의 염을 피린딘 또는 피리딘 유도체와 반응시키거나, 일반식(Ⅲ)의 7-아미노세펨 화합물 또는 그의 산부가염을 일반식(Ⅳ)의 2-(2-아미노티아졸-4-일)-2-신(syn)-옥스이미노아세트산 또는 이의 활성 유도체와 반응시키고, α) 보호그룹이 존재하는 경우에는 이를 제거시키고 β) 경우에 따라 수득된 생성물 생리학적으로 허용되는 산 부가염을 전환시킴을 특징으로하여 일반식(Ⅰ)의 세펨 화합물 및 그의 생리학적으로 허용되는 산부가염을 제조하는 방법.
    상기식중 R1은 수소 또는 할로겐을 나타내고, R2는 수소 또는 C1-C6- 알킬을 나타내며 A는 동일 또는 상이한 치환체 즉 임의 치환된 C1-C6-알킬(이때 두개의 알킬그룹은 결합하여 한개의 원자가 헤테로원자에 의해 치환될 수 있으며 추가로 하나 또는 두개의 이중결합을 함유할 수 있는 치환가능한 디-내지데칼-메틸렌 환을 형성할 수 있음);
    시아노 -C1-C3-알킬, 에폭시-C2-C6-알킬, 트리플루오로메틸 또는 펜타플루오로에틸; 하이드록시이미노메틸 또는 C1-C4-알콕시이미노메틸; 임의 치환된 C2-C|6-알케닐; C2-C6-알키닐; C8-C7-사이클로알킬 또는 C3-C|7-사이클로알킬메틸, 이때 이 두치환체는 또한 치환될 수 있음;
    C4-C7-사이클로알케닐; 임의 치환된 C1-C6-알콕시; 에폭시-C|2-C6-알콕시; C2-C6-알케닐옥시 또는 C2-C6-알키닐올시; 할로겐, 시아노, 하이드록실 또는 메르캅토; C1-C6-알킬설포닐, C1-C6-알킬설피닐 또는 C1-C6-알킬티오, 이때 알킬 부분이 염의 치환됨; 메틸설포닐, 메틸설피닐 또는 메틸티오 이때 메틸 잔기상에서는 치환되어 있음;
    C2-C6-알케닐티오, C2-C6-알케닐설피닐 또는 C2-C|6-알케닐설포닐; 임의 치환된 페닐, 벤질 또는 헤테로아릴; 포르밀 또는 케탈화된 포르밀; 케탈화된 형태로도 존재할 수 있는 임의 치환된 C1-C6-알킬카보닐; 알릴카보닐; C1-C6-알킬카보닐아미노; 카복실 또는 C1-C6-알콕시카보닐: 질소상에서 단인치환 또는 디치환될 수 있는 카바모일; 임의 치환된 카바조일; 질소상에서 단일치환될 수 있는 설파모일; 또는 피리딜 또는 4-피리돈-1-일로 단일치환 또는 다치환될 수 있는 피리디늄 잔기
    를 나타내며
    R2O기는 신(syn)위치이고, R3는 피리디늄잔기 A에 상응하는 피리딘 또는 치환된 피리딘에 의해 치환될 수 있는 기를 나타내며 일반식(Ⅲ)의 아미노그룹은 반응성 유도체 형태로 존재할 수 있고, R4는 수소 또는 아미노 보호기를 나타낸다.
  2. 제1항에 있어서, 치환체 R3의 친핵성 치환반응을 중성 염 이온 특히 이오다이드 또는 티오시아네이트 이온 존재하에 시행하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR8202031A 1981-05-12 1982-05-10 세팔로스포린 유도체의 제조방법 KR880001541B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19813118732 DE3118732A1 (de) 1981-05-12 1981-05-12 Cephalosporinderivate und verfahren zu ihrer herstellung
DE3118732.3 1981-05-12
DEP3118732.3? 1981-05-12

Publications (2)

Publication Number Publication Date
KR830010121A true KR830010121A (ko) 1983-12-26
KR880001541B1 KR880001541B1 (ko) 1988-08-20

Family

ID=6132055

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8202031A KR880001541B1 (ko) 1981-05-12 1982-05-10 세팔로스포린 유도체의 제조방법

Country Status (36)

Country Link
US (1) US5071979A (ko)
EP (1) EP0064740B1 (ko)
JP (2) JPS57192394A (ko)
KR (1) KR880001541B1 (ko)
AR (1) AR241186A1 (ko)
AT (2) ATE19085T1 (ko)
AU (1) AU559727B2 (ko)
BE (1) BE893163A (ko)
BG (1) BG60838B2 (ko)
CA (1) CA1228850A (ko)
CH (1) CH654312A5 (ko)
CS (2) CS248025B2 (ko)
DD (1) DD202720A5 (ko)
DE (2) DE3118732A1 (ko)
DK (1) DK166500B1 (ko)
DZ (1) DZ418A1 (ko)
ES (1) ES511955A0 (ko)
FI (1) FI70715C (ko)
FR (2) FR2511682B1 (ko)
GB (2) GB2098216A (ko)
GR (1) GR75506B (ko)
HU (1) HU186019B (ko)
IE (1) IE53296B1 (ko)
IL (1) IL65737A (ko)
IT (1) IT1157275B (ko)
LU (1) LU88736I2 (ko)
MA (1) MA19474A1 (ko)
MT (1) MTP909B (ko)
NL (3) NL8201913A (ko)
NO (2) NO162022C (ko)
NZ (1) NZ200567A (ko)
PH (1) PH20243A (ko)
PT (1) PT74877B (ko)
SE (1) SE8202961L (ko)
YU (1) YU44346B (ko)
ZA (1) ZA823226B (ko)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
GR76701B (ko) * 1981-09-08 1984-08-29 Lilly Co Eli
JPS5859991A (ja) * 1981-09-14 1983-04-09 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物
US4501739A (en) * 1982-01-19 1985-02-26 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporins
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
ATE30724T1 (de) * 1982-06-28 1987-11-15 Bristol Myers Co Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten.
DE3247613A1 (de) * 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
US4690921A (en) * 1983-10-11 1987-09-01 Yamanouchi Pharmaceutical Co., Ltd. Cephalosporin compounds and salts thereof
EP0138552A3 (en) * 1983-10-17 1986-03-19 Eli Lilly And Company Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins
US4692443A (en) * 1983-10-17 1987-09-08 Eli Lilly And Company 3-bicyclicpyridinium-methyl cephalosporins
JPS6094984A (ja) * 1983-10-28 1985-05-28 Dai Ichi Seiyaku Co Ltd セフエム誘導体
GB8401093D0 (en) * 1984-01-16 1984-02-15 Fujisawa Pharmaceutical Co Cephem compounds
JPS60169486A (ja) * 1984-02-10 1985-09-02 Yamanouchi Pharmaceut Co Ltd ７−アミノ−３−置換メチル−３−セフエム−４−カルボン酸およびその低級アルキルシリル誘導体の製造法
DE3404906A1 (de) * 1984-02-11 1985-08-14 Bayer Ag, 5090 Leverkusen 1-oxadethiacephalosporinderivate sowie verfahren zu ihrer herstellung
IL74822A (en) * 1984-04-17 1989-06-30 Daiichi Seiyaku Co Cephalosporin derivatives and salts thereof and their preparation
JPS60222490A (ja) * 1984-04-17 1985-11-07 Dai Ichi Seiyaku Co Ltd セフアロスポリン誘導体およびその塩
JPS60226884A (ja) * 1984-04-25 1985-11-12 Dai Ichi Seiyaku Co Ltd セフアロスポリン誘導体
EP0160546A3 (en) * 1984-04-26 1986-12-17 Yamanouchi Pharmaceutical Co. Ltd. Cephalosporin compounds, and their production, and medicaments containing them
WO1985005106A1 (en) * 1984-05-09 1985-11-21 Takeda Chemical Industries, Ltd. Cephem compounds
DE3419012A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel oder wachstumsfoerderer in der tieraufzucht oder als antioxidantien
JPH0613530B2 (ja) * 1984-06-08 1994-02-23 武田薬品工業株式会社 セフエム化合物
GB8519606D0 (en) * 1985-08-05 1985-09-11 Fujisawa Pharmaceutical Co 3 7-d substituted-3-cephem compounds
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
EP0238060B1 (en) 1986-03-19 1992-01-08 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives, processes for their preparation and antibacterial agents
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
JPH0242086A (ja) * 1988-08-02 1990-02-13 Banyu Pharmaceut Co Ltd （３‐ヒドロキシ‐４‐ピリドン‐１‐イル）メチル基を有する新規セファロスポリン誘導体
JPH02117679A (ja) * 1989-09-22 1990-05-02 Sankyo Co Ltd チアゾリオメチル置換基を有するセファロスポリン誘導体
US5698703A (en) * 1991-09-10 1997-12-16 Bristol-Myers Squibb Company Syn-isomer of thiazolyl intermediate and process for the preparation thereof
US5594129A (en) * 1991-09-10 1997-01-14 Bristol-Myers Squibb Company Process for the preparation of a cephalosporin antibiotic
EP0554004A3 (en) * 1992-01-27 1993-11-24 Katayama Seisakusho Cephem compounds and antibacterial agents
JPH0741485A (ja) * 1993-07-30 1995-02-10 Katayama Seiyakushiyo:Kk セフェム誘導体およびそれを含有する抗菌剤
US5593985A (en) * 1994-05-23 1997-01-14 Korea Institute Of Science And Technology Cephalosporin compounds
DE4440141A1 (de) * 1994-11-10 1996-05-15 Hoechst Ag Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
JPH09110877A (ja) 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
ATE341554T1 (de) * 1996-04-04 2006-10-15 Shionogi & Co Cephemverbindungen und medikamente die diese verbindungen enthalten
US5929086A (en) * 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
KR100293728B1 (ko) * 1998-05-22 2001-09-17 손 경 식 결정성세피롬황산염의제조방법
TWI335332B (en) 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
ES2335013T3 (es) * 2003-05-23 2010-03-18 Theravance, Inc. Antibioticos de glucopeptido-cefalosporina reticulados.
JP4754275B2 (ja) * 2005-06-13 2011-08-24 川崎重工業株式会社 壁掛機器用防振支持構造
US20130065874A1 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
CN102584856A (zh) * 2011-12-27 2012-07-18 开封豫港制药有限公司 硫酸头孢匹罗的制备方法
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
WO2017096472A1 (en) * 2015-12-10 2017-06-15 Naeja-Rgm Pharmaceuticals Inc. Cephem compounds, their production and use
CN105646543B (zh) * 2016-03-17 2018-03-27 天津大学 一种头孢喹肟晶体及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1082962A (en) * 1963-05-28 1967-09-13 Glaxo Lab Ltd Derivatives of 7-aminocephalosporanic acid
GB1052068A (ko) * 1963-11-04
GB1310642A (en) * 1970-11-09 1973-03-21 Pfizer Alpha-sulfo-and alpha-sulfoalkylacylcephalosporins
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4200746A (en) * 1974-12-20 1980-04-29 Glaxo Laboratories, Ltd. Cephalosporins
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4336353A (en) * 1979-09-11 1982-06-22 Ciba-Geigy Corporation Salts of 3-methyl-2-(2',4'-dimethyl-phenylimino)-4-thiazoline with polymers containing sulfonic acid groups
EP0027599B1 (en) * 1979-10-12 1984-10-03 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
GR75644B (ko) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
US4367228A (en) * 1980-10-29 1983-01-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compound and composition
US4427677A (en) * 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4336253A (en) * 1981-03-11 1982-06-22 Eli Lilly And Company Cephalosporin antibiotics
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
US4379787A (en) * 1981-10-02 1983-04-12 Eli Lilly And Company Oximino-substituted cephalosporin compounds
US4501739A (en) * 1982-01-19 1985-02-26 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporins
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR880001541B1 (ko) 1988-08-20
FR2511682A1 (fr) 1983-02-25
GB2144424A (en) 1985-03-06
JPS57192394A (en) 1982-11-26
IE821129L (en) 1982-11-12
FI70715B (fi) 1986-06-26
EP0064740A3 (en) 1983-11-23
CH654312A5 (de) 1986-02-14
SE8202961L (sv) 1982-11-13
IL65737A (en) 1986-11-30
HU186019B (en) 1985-05-28
DZ418A1 (fr) 2004-09-13
US5071979A (en) 1991-12-10
EP0064740B1 (de) 1986-04-09
DK166500B1 (da) 1993-06-01
GB2144424B (en) 1986-02-12
AR241186A1 (es) 1992-01-31
FR2515654B1 (fr) 1986-11-14
CA1228850A (en) 1987-11-03
NO162022B (no) 1989-07-17
BG60838B2 (bg) 1996-04-30
ES8304143A1 (es) 1983-02-16
AU559727B2 (en) 1987-03-19
ATA184382A (de) 1986-05-15
NL940003I1 (nl) 1994-04-05
NO1999008I1 (no) 1999-05-27
NO162022C (no) 1989-10-25
CS415891A3 (en) 1992-04-15
PT74877B (de) 1984-11-26
GB2098216A (en) 1982-11-17
DE3270360D1 (en) 1986-05-15
NZ200567A (en) 1985-01-31
DD202720A5 (de) 1983-09-28
BE893163A (fr) 1982-11-12
GB8423511D0 (en) 1984-10-24
FR2511682B1 (fr) 1985-06-28
IT8221182A0 (it) 1982-05-10
MA19474A1 (fr) 1982-12-31
AU8358982A (en) 1982-11-18
MTP909B (en) 1985-02-28
IL65737A0 (en) 1982-08-31
FI70715C (fi) 1986-10-06
ATE19085T1 (de) 1986-04-15
IT1157275B (it) 1987-02-11
GR75506B (ko) 1984-07-24
NO821562L (no) 1982-11-15
LU88736I2 (fr) 1996-08-23
NL950013I1 (nl) 1997-02-03
NL940003I2 (nl) 1997-02-03
EP0064740A2 (de) 1982-11-17
DE3118732A1 (de) 1982-12-02
SE8202961D0 (sv) 1982-05-11
FI821644L (fi) 1982-11-13
JPH0144190B2 (ko) 1989-09-26
ZA823226B (en) 1983-03-30
DK211382A (da) 1982-11-13
YU98382A (en) 1985-08-31
NL8201913A (nl) 1982-12-01
PT74877A (de) 1982-06-01
FR2515654A1 (fr) 1983-05-06
NL950013I2 (nl) 1997-02-03
IE53296B1 (en) 1988-10-12
PH20243A (en) 1986-11-10
FI821644A0 (fi) 1982-05-10
ES511955A0 (es) 1983-02-16
CS248025B2 (en) 1987-01-15
JPS6419082A (en) 1989-01-23
YU44346B (en) 1990-06-30
AT381945B (de) 1986-12-10
JPH0670068B2 (ja) 1994-09-07

Similar Documents

Publication Publication Date Title
KR830010121A (ko) 세팔로스포린 유도체의 제조방법
KR840004117A (ko) 세팔로스포린 유도체의 제조방법
FI812693L (fi) Benzoxazinderivat
KR830009118A (ko) 세펨화합물의 제조방법
IE791565L (en) Crop cutting apparatus
NO164537C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive r(+)- og s(-)-carbazolderivater, og r(-)- og s(+)-4-(2,3-epoxypropoxy)-carbazol for anvendelse ved fremgangsmaaten.
US4482709A (en) Inclusion compounds of cyclodextrin with sulfur-containing compounds
SE8204237D0 (sv) Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav
AU561450B2 (en) 2-amino-3-acylamino-6-benzylamino pyridine derivatives
ES462065A1 (es) Procedimiento para la preparacion de derivados de tiazolidi-na.
BG38334A3 (en) Method for preparing pyrolidinic derivatives
KR840000533A (ko) 화합물의 제조방법
KR840007014A (ko) 세팔로스포린 유도체의 제조방법
KR840008018A (ko) 트리아졸유도체의 제조방법
KR880011122A (ko) 4-티오퀴나졸린 유도체, 이의 제조방법 및 약제학적 조성물
AU556922B2 (en) Pyridobenzodiazepinone derivatives
KR850001761A (ko) 세팔로스포린 유도체의 제조방법
KR850004493A (ko) 헤테로사이클릭 그룹을 함유하는 이미다조 퀴놀린 유도체의 제조방법
ES8602811A1 (es) Un procedimiento para preparar un compuesto cefemico
NZ220195A (en) 2-pyridyl-penem derivatives and pharmaceutical compositions
ES468462A1 (es) Ÿun procedimiento para la preparacion de nuevos derivados depiridinaÿ
ES454280A1 (es) Procedimiento para preparar 1-(2-(beta-naftiloxi)-etil)-3-metilpirazolona-(5).
GB1451029A (en) Imidazole derivatives
EP0008950A3 (en) Pyrimido(1,6-a)indole derivatives and intermediates therefor, processes for their preparation, pharmaceutical compositions containing the derivatives and their use
KR830006309A (ko) 세펨화합물의 제조방법